Literature DB >> 32266694

Chloroquine for COVID-19 Infection.

Nicholas Moore1.   

Abstract

Entities:  

Year:  2020        PMID： 32266694     DOI： 10.1007/s40264-020-00933-4

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  11 in total

Review 1.  Mass spectrometric investigations of caloric restriction mimetics.

Authors:  Michael J Bibyk; Melanie J Campbell; Amanda B Hummon
Journal:  Proteomics       Date:  2021-02-23       Impact factor: 3.984

Review 2.  Hydroxychloroquine and Chloroquine in Prophylaxis and Treatment of COVID-19: What Is Known?

Authors:  Pathiyil Ravi Shankar; Subish Palaian; Shabaz Mohiuddin Gulam
Journal:  J Pharm Bioallied Sci       Date:  2020-10-06

3.  A New Drug-Drug Interaction Between Hydroxychloroquine and Metformin? A Signal Detection Study.

Authors:  Jean-Louis Montastruc; Pierre-Louis Toutain
Journal:  Drug Saf       Date:  2020-07       Impact factor: 5.606

4.  Does Ibuprofen Worsen COVID-19?

Authors:  Nicholas Moore; Bruce Carleton; Patrick Blin; Pauline Bosco-Levy; Cecile Droz
Journal:  Drug Saf       Date:  2020-07       Impact factor: 5.606

5.  Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel.

Authors:  Zheng Zequn; W U Yujia; Q I A N Dingding; L I A N Jiangfang
Journal:  Eur J Pharmacol       Date:  2020-12-17       Impact factor: 4.432

6.  Chloroquine, an Anti-Malaria Drug as Effective Prevention for Hantavirus Infections.

Authors:  Valentijn Vergote; Lies Laenen; Raf Mols; Patrick Augustijns; Marc Van Ranst; Piet Maes
Journal:  Front Cell Infect Microbiol       Date:  2021-03-15       Impact factor: 5.293

7.  What Is the Best Drug to Treat COVID-19? The Need for Randomized Controlled Trials.

Authors:  Silvia Ottaviani; Justin Stebbing
Journal:  Med (N Y)       Date:  2020-05-19

8.  "Off-label" use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers.

Authors:  Alexandre Gérard; Serena Romani; Audrey Fresse; Delphine Viard; Nadège Parassol; Aurélie Granvuillemin; Laurent Chouchana; Fanny Rocher; Milou-Daniel Drici
Journal:  Therapie       Date:  2020-05-07       Impact factor: 2.070

Review 9.  A review of medications used to control and improve the signs and symptoms of COVID-19 patients.

Authors:  Kiavash Hushmandi; Saied Bokaie; Mehrdad Hashemi; Ebrahim Rahmani Moghadam; Mehdi Raei; Farid Hashemi; Mahdi Bagheri; Solomon Habtemariam; Seyed Mohammad Nabavi
Journal:  Eur J Pharmacol       Date:  2020-09-19       Impact factor: 4.432

10.  Epidemiological and Clinical Characteristics of COVID-19: A Retrospective Multi-Center Study in Pakistan.

Authors:  Mehmood Ahmad; Bilal Mahmood Beg; Arfa Majeed; Sadaf Areej; Sualeha Riffat; Muhammad Adil Rasheed; Sammina Mahmood; Rana Muhammad Zahid Mushtaq; Mian Abdul Hafeez
Journal:  Front Public Health       Date:  2021-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.